NDAORALCAPSULE
Approved
Feb 2007
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
28
Mechanism of Action
dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. The exact mode of therapeutic action in ADHD and BED is not known.
Clinical Trials (5)
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Started Sep 2025
105 enrolled
Obesity and OverweightBinge Eating Disorder
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder
Started Jun 2019
150 enrolled
Binge-eating Disorder
Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
Started Jan 2014
418 enrolled
Binge Eating Disorder
Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers
Started Jul 2013
30 enrolled
Healthy Volunteers
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
Started Nov 2012
383 enrolled
Binge Eating Disorder